$Nanobiotix (NBTX.US)$ NEWS Nanobiotix Announces Progress in...

Jaguar8 commented on a stock · May 22, 2024 04:21

NEWS

Nanobiotix Announces Progress in Global NBTXR3 Development Collaboration Highlighting Robust Pipeline and Pathway to Long-Term Growth

Nanobiotix has announced significant progress in its global collaboration with Janssen to develop and commercialize its radioenhancer NBTXR3. This collaboration aims to expand the application of NBTXR3 in treating cancer patients who undergo radiotherapy. Key updates include the removal of a planned futility analysis for the ongoing Phase 3 head and neck cancer trial, with interim analysis results expected in 1H2026. Additionally, the company received FDA approval to proceed with a new Phase 2 study for lung cancer. These advancements are part of a broader strategy to leverage NBTXR3’s potential to fund the development of other nanoparticle-based therapies. Nanobiotix is also aligning with Janssen on global manufacturing and operational strategies, including a transfer of trial sponsorship to Janssen and a focus on expanding indications beyond head and neck and lung cancer.

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

Translate

Report

3800 Views

Comment

Jaguar8

Spread kindness and love. Life is short. Don’t let greed eat you.

6638

Followers

Following

71K

Visitors